P16.01.A Factors predicting cognitive impairment after intrathecal methotrexate treatment in patients with non-small cell lung cancer and leptomeningeal disease
Authors: N Vilariño, I Esparragosa, J Marín, M Alemany, R Velasco, M Jové, J Brenes, R Palmero, I Brao, M Arellano, R Sala, J Bruna, E Nadal, M Simó